India
· Delayed Price · Currency is INR AstraZeneca Pharma India Statistics
Total Valuation
NSE:ASTRAZEN has a market cap or net worth of INR 171.72 billion. The enterprise value is 166.92 billion.
| Market Cap | 171.72B |
| Enterprise Value | 166.92B |
Important Dates
The last earnings date was Tuesday, February 4, 2025.
| Earnings Date | Feb 4, 2025 |
| Ex-Dividend Date | Jul 5, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 4.16M |
Valuation Ratios
The trailing PE ratio is 177.08.
| PE Ratio | 177.08 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 25.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 172.14 |
| EV / Sales | 10.31 |
| EV / EBITDA | 80.60 |
| EV / EBIT | 86.56 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | n/a |
| Interest Coverage | 271.61 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 17.77% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 20.24M |
| Profits Per Employee | 1.21M |
| Employee Count | 940 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.43% in the last 52 weeks. The beta is 0.34, so NSE:ASTRAZEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | +25.43% |
| 50-Day Moving Average | 7,028.27 |
| 200-Day Moving Average | 6,828.23 |
| Relative Strength Index (RSI) | 37.78 |
| Average Volume (20 Days) | 18,708 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ASTRAZEN had revenue of INR 16.19 billion and earned 969.70 million in profits. Earnings per share was 38.78.
| Revenue | 16.19B |
| Gross Profit | 6.96B |
| Operating Income | 1.93B |
| Pretax Income | 1.32B |
| Net Income | 969.70M |
| EBITDA | 2.04B |
| EBIT | 1.93B |
| Earnings Per Share (EPS) | 38.78 |
Balance Sheet
The company has 4.97 billion in cash and 171.20 million in debt, giving a net cash position of 4.80 billion.
| Cash & Cash Equivalents | 4.97B |
| Total Debt | 171.20M |
| Net Cash | 4.80B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 6.79B |
| Book Value Per Share | 271.70 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 42.98%, with operating and profit margins of 11.91% and 5.99%.
| Gross Margin | 42.98% |
| Operating Margin | 11.91% |
| Pretax Margin | 8.17% |
| Profit Margin | 5.99% |
| EBITDA Margin | 12.60% |
| EBIT Margin | 11.91% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 24.00, which amounts to a dividend yield of 0.35%.
| Dividend Per Share | 24.00 |
| Dividend Yield | 0.35% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | 0.34% |
| Earnings Yield | 0.56% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |